Michael Singer
ORCID: 0000-0002-0149-4802
· 2 papers in corpus
Although intra-ocular antivascular endothelial growth factor (VEGF) injections are the standard of care for patients with diabetic macular oedema (DME), some fail this treatment. This begets the need for alternative therapies for these pati…